Day: March 11, 2023

VANCOUVER, British Columbia, March 10, 2023 (GLOBE NEWSWIRE) — Blender Bites Limited. (the “Company”, “Blender Bites” or “Blender”), (CSE: BITE, FWB: JL4, WKN: A3DMEJ), a two time award-winning Canadian company involved in the development and marketing of a line of premium, organic and plant-based pre-portioned frozen functional foods, is pleased to announce the appointment of Mr. Steve Pear, former CEO of Odwalla, a subsidiary of the Coca-Cola Company (“Coca-Cola”), as the Company’s Chief Operating Officer (COO). Mr. Pear has extensive experience in the beverage and consumer packaged goods (CPGs) space, bringing over three decades of executive level expertise to his new role with Blender Bites. Mr. Pear’s impressive career includes 22 years with industry giant Coca-Cola where he held executive level roles under subsidiaries...

CHIHUAHUA, Mexico, March 10, 2023 (GLOBE NEWSWIRE) — GCC, S.A.B. de C.V. (BMV: GCC* or “the Company”), a leading producer of cement and concrete in the United States and Mexico, announced today that it has entered into a settlement agreement (the “Agreement”) reaching a mutual release with Compañía de Inversiones Mercantiles, S.A. (“CIMSA”). Pursuant to the Agreement, GCC and CIMSA negotiated an amount that satisfied both parties, concluding all disputes between them. This Agreement does not preclude GCC´s option to recover the settlement amount from other third parties as the case may be. The Agreement does not affect, in any way, the Company’s solid financial position, the fulfillment of obligations and liabilities, or the normal course of business. This document is submitted in compliance with Article 54...

CAMBRIDGE, Mass., March 10, 2023 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today provided an update about its capital resources. A de minimis amount of Mersana’s capital is currently held in a checking account at Silicon Valley Bank (SVB). The balance of the company’s capital resources is held in a custodial account managed by another institution and in money market funds of institutions other than SVB. Mersana has a loan and security agreement with Oxford Finance LLC and SVB. As previously disclosed, to date the company has borrowed $25 million under the loan agreement, and $15 million is available to be borrowed at the company’s...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 10, 2023 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU) , an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, announces that it has filed an amended and restated offering document for its previously announced private placement offering (the “Offering”) of units of the Company (“Units”). The Units offered will be offered to purchasers resident in the provinces set forth in the Offering Document (as defined below), pursuant to the listed issuer financing exemption under Part 5A of National Instrument 45-106 – Prospectus Exemptions and will not be subject to a hold period...